Inspire Medical Systems Total Liabilities 2017-2025 | INSP

Inspire Medical Systems total liabilities from 2017 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Inspire Medical Systems Annual Total Liabilities
(Millions of US $)
2024 $119
2023 $104
2022 $69
2021 $66
2020 $51
2019 $41
2018 $36
2017 $24
2016 $0
Inspire Medical Systems Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $95
2024-12-31 $119
2024-09-30 $100
2024-06-30 $90
2024-03-31 $97
2023-12-31 $104
2023-09-30 $95
2023-06-30 $89
2023-03-31 $67
2022-12-31 $69
2022-09-30 $57
2022-06-30 $65
2022-03-31 $65
2021-12-31 $66
2021-09-30 $59
2021-06-30 $52
2021-03-31 $50
2020-12-31 $51
2020-09-30 $43
2020-06-30 $38
2020-03-31 $38
2019-12-31 $41
2019-09-30 $37
2019-06-30 $33
2019-03-31 $32
2018-12-31 $36
2018-09-30 $32
2018-06-30 $31
2018-03-31 $33
2017-12-31 $24
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.914B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.946B 59.99
Hims & Hers Health (HIMS) United States $12.884B 133.86
Tempus AI (TEM) United States $12.253B 0.00
IRhythm Technologies (IRTC) United States $4.705B 0.00
Privia Health (PRVA) United States $2.805B 191.75
Hinge Health (HNGE) United States $2.743B 0.00
Schrodinger (SDGR) United States $1.958B 0.00
Enovis (ENOV) United States $1.904B 10.62
Phreesia (PHR) United States $1.677B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Omnicell (OMCL) United States $1.424B 25.12
Azenta (AZTA) United States $1.410B 65.55
10x Genomics (TXG) United States $1.327B 0.00
Fulgent Genetics (FLGT) United States $0.661B 0.00
Claritev (CTEV) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.623B 0.00
Talkspace (TALK) United States $0.518B 154.75
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.67
Outset Medical (OM) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.276B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.112B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.095B 3.61
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.027B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00